| 000 | 01903 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250514170523.0 | ||
| 264 | 0 | _c20040422 | |
| 008 | 200404s 0 0 eng d | ||
| 022 | _a1198-743X | ||
| 024 | 7 |
_a10.1111/j.1198-743x.2003.00864.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSchneider, Véronique | |
| 245 | 0 | 0 |
_aPeptide insertions in reverse transcriptase pol gene of human immunodeficiency virus type 1 as a rare cause of persistent antiretroviral therapeutic failure. _h[electronic resource] |
| 260 |
_bClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases _cFeb 2004 |
||
| 300 |
_a127-36 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Resistance, Viral |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGenes, pol _xgenetics |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 |
_aHIV Reverse Transcriptase _xgenetics |
| 650 | 0 | 4 |
_aHIV-1 _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aPeptides |
| 650 | 0 | 4 |
_aReverse Transcriptase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aTreatment Failure |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aLegoff, Jérôme | |
| 700 | 1 | _aBélec, Laurent | |
| 700 | 1 | _aDelphin, Nathalie | |
| 700 | 1 | _aDutreuil, Corinne | |
| 700 | 1 | _aKara-Mostefa, Ali | |
| 700 | 1 | _aRozenbaum, Willy | |
| 700 | 1 | _aNicolas, Jean-Claude | |
| 773 | 0 |
_tClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases _gvol. 10 _gno. 2 _gp. 127-36 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1198-743x.2003.00864.x _zAvailable from publisher's website |
| 999 |
_c14483322 _d14483322 |
||